Skip to main content

Prior Covid Infection Is As Effective At Preventing The Virus As Vaccination, U.K. Study Suggests

Published 1 year ago
By Forbes
Photo by RODGER BOSCH / AFP) (Photo by RODGER BOSCH/AFP via Getty Images)

TOPLINE People who previously contracted Covid-19 have about the same level of protection against contracting the disease as those fully inoculated with two key vaccines, according to the findings of a study published Monday which adds to a growing and sometimes contradictory body of research on natural immunity.

KEY FACTS

The study published by the U.K.’s Office of National Statistics (ONS) looked at more than 8,000 positive coronavirus tests across Britain between May and August, when delta was the dominant variant. 

During this time, people who had previously recovered from Covid-19 were about 71% less likely to contract it a second time, the analysis found. 

This represents about the same level of protection the study found was offered by two doses of the vaccines made by Pfizer and AstraZeneca, which have been prominently used in Europe’s inoculation drive. 

Two doses of the Pfizer vaccine reduced the risk of contracting Covid-19 by around 73% compared to 62% for AstraZeneca’s vaccine. 

The overlap in confidence intervals meant there “was no evidence” that full vaccination was any more effective in preventing Covid-19 than previous natural infection, the researchers concluded. 

The study, which has not been peer reviewed, found previous infection was similarly effective at preventing symptomatic Covid-19, but did not delve into the differences between natural infection and vaccines in preventing severe disease.

KEY BACKGROUND 

There have been dozens of studies conducted on natural immunity, with many coming up with different results. A study out of Israel last month indicated people with two vaccine shots actually had a six-fold higher chance of getting infected with the delta variant than those who had previously contracted Covid-19. In this study, vaccinated people also had a higher risk of symptomatic infection, and a 6.7-fold higher chance of being hospitalized. However, other studies have signaled that mRNA vaccines produce more antibodies, more reliably than previous infection from Covid-19 does. Regardless, scientists are still strongly recommending the previously infected get vaccinated against Covid-19 because of the many remaining questions about natural immunity, its level of protection and how long it can last. 

CRUCIAL QUOTE 

Studies have also consistently shown that vaccination on top of previous infection offers even higher levels of immunity. As highlighted by Sarah Croft, the head of analysis for the U.K. study, “the highest protection was found among those who had experienced a past infection followed by two vaccines.” 

TANGENT 

The study also found both vaccines were less effective at preventing Covid-19 during the delta wave than during the previous alpha wave of the virus. The efficacy of two doses of the Pfizer vaccine was 80% during the earlier period, compared to 76% for AstraZeneca’s vaccine. Croft said this trend may be further evidence of the waning immunity of vaccines as the data “includes results from participants who had experienced a longer average time period since their second Covid vaccination.” 

FURTHER READING

“If You’ve Had Covid, Do You Need the Vaccine?” (The New York Times)

Sign Up for Our Newsletter Daily Update

Get the best of Forbes Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.
Related Topics: #Africa, #Coronavirus, #Coronavirus Outbreak, #Coronavirus Pandemic, #Coronavirus Vaccine, #COVID-19, #Covid-19 Vaccine, #Featured, #Forbes Africa, #News Letter.